back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-08-21 19:57 Tx date 2024-08-16 |
$HBP
Helix BioPharma Corp. |
ANTAS, JACEK MAREK
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-2,553,280 vol |
638,320 | |
| Filed 2024-08-21 19:56 Tx date 2024-08-16 |
$HBP
Helix BioPharma Corp. |
ANTAS, JACEK MAREK
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-10,000,000 vol |
2,500,000 | |
| Filed 2024-07-22 19:16 Tx date 2024-07-19 |
$HBP
Helix BioPharma Corp. |
ANTAS, JACEK MAREK
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,640,000
+12,000,000 vol $0.22 each |
12,500,000 | |
| Filed 2023-01-10 11:38 Tx date 2023-01-09 |
$HBP
Helix BioPharma Corp. |
ANTAS, JACEK MAREK
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$130,000
+500,000 vol $0.26 each |
500,000 | |
| Filed 2023-01-10 11:35 Tx date 2022-04-18 |
$HBP
Helix BioPharma Corp. |
ANTAS, JACEK MAREK
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-11-08 10:31 Tx date 2022-11-03 |
$HBP
Helix BioPharma Corp. |
ANTAS, JACEK MAREK
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$198,000
+1,100,000 vol $0.18 each |
3,191,600 | |
| Filed 2022-04-28 11:27 Tx date 2022-04-18 |
$HBP
Helix BioPharma Corp. |
ANTAS, JACEK MAREK
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
1,555,500 | ||
| Filed 2022-04-28 11:27 Tx date 2022-04-18 |
$HBP
Helix BioPharma Corp. |
ANTAS, JACEK MAREK
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,091,600 |